TrialJournal of diabetes investigation2022

Comparisons of efficacy and safety in insulin glargine and lixisenatide plus glulisine combination therapy with multiple daily injection therapy in Japanese patients with type 2 diabetes.

Yuji Kawaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.